Hinge Health Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Net Income	-510.27	-528.26	-11.93	-108.14
Depreciation & Amortization	5	5.13	5.95	5.63
Stock-Based Compensation	654.69	643.01	0.74	1.65
Other Adjustments	59.85	53.57	40.74	27.55
Change in Receivables	-41.21	-26.63	-1.34	-23.13
Changes in Inventories	-1.38	-4.76	0.61	10.57
Changes in Accounts Payable	24.94	29.41	-10.98	11.56
Changes in Unearned Revenue	123.44	83.22	77.16	35.97
Changes in Other Operating Activities	-105.46	-83.25	-51.95	-25.56
Operating Cash Flow	209.6	171.44	49	-63.91
Operating Cash Flow Growth	142.07%	249.87%	-	-
Capital Expenditures	-0.74	-0.71	-1.04	-1.98
Purchases of Intangible Assets	-6.1	-5.36	-2.73	-2.64
Purchases of Investments	-441.07	-472.29	-324.54	-453.34
Proceeds from Sale of Investments	403.56	368.59	346.63	459.45
Payments for Business Acquisitions	-	-4	-	-
Investing Cash Flow	-58.76	-113.76	18.31	1.5
Issuance of Common Stock	129.57	265.2	0.61	0.49
Repurchase of Common Stock	-303.52	-360.26	-	-
Net Common Stock Issued (Repurchased)	-173.96	-95.05	0.61	0.49
Other Financing Activities	-34.42	-55.42	-2.81	-2.85
Financing Cash Flow	-267.42	-150.47	-2.2	-2.36
Net Cash Flow	-102.17	-92.79	65.11	-64.76
Free Cash Flow	208.86	170.73	47.96	-65.89
Free Cash Flow Growth	22.33%	255.97%	-	-
FCF Margin	32.31%	29.04%	12.29%	-22.51%
Free Cash Flow Per Share	2.88	3.13	3.54	-5.06
Levered Free Cash Flow	-497.69	-395.05	7.82	-71.95
Unlevered Free Cash Flow	-448.25	-518.37	-14.08	-93.84

SEC Filings: 10-K · 10-Q